TTNP
Titan Pharmaceuticals
TTNP
TTNP
Delisted
TTNP was delisted on the 1st of October, 2025.
17 hedge funds and large institutions have $216K invested in Titan Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
80% less capital invested
Capital invested by funds: $1.1M → $216K (-$885K)
Holders
17
Holding in Top 10
–
Calls
$65K
Puts
$3K
Top Buyers
| 1 | +$62.7K | |
| 2 | +$14.9K | |
| 3 | +$8.56K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$1.35K |
Top Sellers
| 1 | -$89K | |
| 2 | -$37K | |
| 3 | -$29.3K | |
| 4 |
VF
Virtu Financial
New York
|
-$3.61K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$451 |